Skip to main content

AGEN Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Agenus Inc. News

The Case For a Biotech Snapback

After a challenging year, shares of biotech companies could see rebound following tax loss selling, Bret Jensen says.

Jensen: How to Play Agenus Using Options

Real Money's Bret Jensen outlines simple strategy to use with cancer drug maker.

Bristol-Myers Higher on Progress With Lymphoma-Drug Trial

Bristol-Myers Squibb shares climb after the drugmaker reports progress with a Phase 3 study of a lymphoma treatment.

Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, and Thermo Fisher

These stocks that fell in the past week could be buy-the-dip opportunities. Recent losers include Okta, Match Group, Procter & Gamble, and more.

Agenus Shares Blast Higher on Deal with Bristol Myers

Bristol Myers Squibb agrees to pay Agenus up to $1.56 billion for the rights to its experimental immuno-cancer treatment.

Breaking News

Las Vegas Strip May Lose a Major Sports Franchise

Sin City usually gets what it wants. That may not happen this time.

Steve Jobs Gets Posthumous Award From President Joe Biden

Jobs was one of 17 people to be awarded the Presidential Medal of Freedom.

Target Has a Surprising New Idea For Cereal Fans

This throwback will excite fans who fondly remember cereals from their childhoods.

TikTok Faces a New Major Threat

The popular short-form social media company is in the hot seat once again in the U.S.